Company news
HemoGenyx Pharmaceuticals PLC news in 2021
HemoGenyx Pharmaceuticals PLC's news releases, calls and decks from 2021, newest first.
Hemo-CAR-T partnership with WuXi ATU
December 20, 2021
Convertible Loans Repayment
November 24, 2021
Lease of New York Mink Building Custom Laboratory
October 18, 2021
CDX Licence Agreement
October 13, 2021
U.S. Approval of Monoclonal Antibody Patent
September 2, 2021
Appointment of Business Advisor & Board Observer
July 26, 2021
Corporate Presentation
July 2, 2021
Changes to 2021 AGM Arrangements
June 15, 2021
U.S. Approval and Issuance of CDX Antibody Patent
June 2, 2021
Termination of Mint Facility; Admission of Shares
May 26, 2021
Loan Notes Sale & Conversion; Facility Terminated
May 18, 2021
Publication of Supplementary Prospectus
May 12, 2021
Conversion of Convertible Loan Notes
May 5, 2021
CDX Option Update
April 14, 2021
CDX Antibody Update
April 1, 2021
Allotment of Shares
March 29, 2021
H.C. Wainwright Investment Conference
March 8, 2021
HEMO-CAR-T Update
March 3, 2021
Draw Down Under Financing Facility Agreement
February 3, 2021
Publication of Prospectus
January 29, 2021
Update on CDX Antibody Development
January 13, 2021
Result of General Meeting
January 6, 2021
CAR-T Master Translational Agreement with Penn
January 5, 2021
Decks in 2021
- Investor Presentation (July 2021)
Investor deck · 16 slides · Jul 2, 2021